Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiji Yoshimura

Showing results (221-230 of 297) with videos related to

Pageof 30
Sort By:
Scientific Reports|December 17, 2020
Brain structural network alterations related to serum cortisol levels in drug-naïve, first-episode major depressive disorder patients: a source-based morphometric studyLeHoa Nguyen, Shingo Kakeda, Keita Watanabe, et al.
Neuropsychiatric Disease and Treatment|February 19, 2019
Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptomsShingo Kakeda, Keita Watanabe, Asuka Katsuki, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 30, 2007
Blood levels of catecholamine metabolites and brain-derived neurotrophic factor in a case of Sydenham's choreaWakako Umene, Reiji Yoshimura, Hikaru Hori, et al.
Neuropsychiatric Disease and Treatment|October 16, 2018
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trialsTaro Kishi, Kazuto Oya, Yuki Matsui, et al.
Human Psychopharmacology|June 17, 2011
No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patientsAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Taro Kishi, et al.
Scientific Reports|June 23, 2017
Voxel-based morphometric brain comparison between healthy subjects and major depressive disorder patients in Japanese with the s/s genotype of 5-HTTLPRNatsuki Igata, Shingo Kakeda, Keita Watanabe, et al.
Human Psychopharmacology|October 28, 2011
Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary reportAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Taro Kishi, et al.
Frontiers in Psychiatry|March 22, 2021
Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary FindingsNaomichi Okamoto, Koji Yoshino, Shogo Kitagawa, et al.
Journal of Human Genetics|May 24, 2013
Further evidence of an association between a genetic variant in BMP7 and treatment response to SSRIs in major depressive disorderKosei Esaki, Kenji Kondo, Masakazu Hatano, et al.
Psychiatry Research|August 9, 2015
Relationship between the catechol-O-methyl transferase Val108/158Met genotype and brain volume in treatment-naive major depressive disorder: Voxel-based morphometry analysisKeita Watanabe, Shingo Kakeda, Reiji Yoshimura, et al.
Pageof 30

Showing results (221-230 of 297) with videos related to

Sort By:
Pageof 30
Scientific Reports|December 17, 2020
Brain structural network alterations related to serum cortisol levels in drug-naïve, first-episode major depressive disorder patients: a source-based morphometric studyLeHoa Nguyen, Shingo Kakeda, Keita Watanabe, et al.
Neuropsychiatric Disease and Treatment|February 19, 2019
Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptomsShingo Kakeda, Keita Watanabe, Asuka Katsuki, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 30, 2007
Blood levels of catecholamine metabolites and brain-derived neurotrophic factor in a case of Sydenham's choreaWakako Umene, Reiji Yoshimura, Hikaru Hori, et al.
Neuropsychiatric Disease and Treatment|October 16, 2018
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trialsTaro Kishi, Kazuto Oya, Yuki Matsui, et al.
Human Psychopharmacology|June 17, 2011
No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patientsAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Taro Kishi, et al.
Scientific Reports|June 23, 2017
Voxel-based morphometric brain comparison between healthy subjects and major depressive disorder patients in Japanese with the s/s genotype of 5-HTTLPRNatsuki Igata, Shingo Kakeda, Keita Watanabe, et al.
Human Psychopharmacology|October 28, 2011
Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary reportAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Taro Kishi, et al.
Frontiers in Psychiatry|March 22, 2021
Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary FindingsNaomichi Okamoto, Koji Yoshino, Shogo Kitagawa, et al.
Journal of Human Genetics|May 24, 2013
Further evidence of an association between a genetic variant in BMP7 and treatment response to SSRIs in major depressive disorderKosei Esaki, Kenji Kondo, Masakazu Hatano, et al.
Psychiatry Research|August 9, 2015
Relationship between the catechol-O-methyl transferase Val108/158Met genotype and brain volume in treatment-naive major depressive disorder: Voxel-based morphometry analysisKeita Watanabe, Shingo Kakeda, Reiji Yoshimura, et al.
Pageof 30